Danske Bank’s Elevance Health ELV Stock Holding History

Danske Bank’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.4M	Buy	122,658 +734	+0.6%	+$272K	0.09%	174
2026 Q1	$35.7M	Sell	121,924 -5,806	-5%	-$1.91M	0.09%	197
2025 Q4	$44.8M	Buy	127,730 +12,212	+11%	+$4.13M	0.1%	161
2025 Q3	$37.3M	Sell	115,518 -145,381	-56%	-$45.2M	0.09%	187
2025 Q2	$101M	Buy	260,899 +45,011	+21%	+$18.1M	0.25%	72
2025 Q1	$93.9M	Buy	215,888 +71,056	+49%	+$28.5M	0.29%	61
2024 Q4	$53.4M	Sell	144,832 -63,224	-30%	-$26.5M	0.16%	106
2024 Q3	$108M	Buy	208,056 +13,905	+7%	+$7.43M	0.36%	44
2024 Q2	$105M	Sell	194,151 -30,941	-14%	-$16.4M	0.39%	40
2024 Q1	$117M	Buy	+225,092	New	+$112M	0.37%	51

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Danske Bank's ELV Position: Q2 2026 in Review

Danske Bank increased its Elevance Health (ELV) stake by 0.6% in Q2 2026, buying an estimated $272K and bringing the position to 122,658 shares worth $47.4M. The position accounts for 0.09% of the portfolio, ranked #174.

Danske Bank first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $117M in Q1 2024. 1,413 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Danske Bank held 122,658 shares of Elevance Health worth $47.4M as of Q2 2026.
Danske Bank bought 734 Elevance Health shares in Q2 2026, an estimated $272K.
Elevance Health made up 0.09% of Danske Bank's portfolio in Q2 2026, its #174 holding.
Danske Bank first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
Danske Bank's Elevance Health position peaked at $117M in Q1 2024.
1,413 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.